ClinicalTrials.gov
ClinicalTrials.gov Menu

Non-small Cell Lung Cancer and Quality of Life (SILKE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00818402
Recruitment Status : Completed
First Posted : January 7, 2009
Last Update Posted : May 29, 2015
Sponsor:
Information provided by (Responsible Party):
Maria Silvoniemi, University of Turku

Brief Summary:
The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Condition or disease
Non Small Cell Lung Cancer

Study Type : Observational
Actual Enrollment : 130 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control
Study Start Date : August 2008
Actual Primary Completion Date : February 2012
Actual Study Completion Date : February 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer
U.S. FDA Resources

Group/Cohort
Non-small cell lung cancer patients



Biospecimen Retention:   Samples With DNA
whole blood


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The patients treated in the clinic of respiratory medicine in Turku, Finland
Criteria

Inclusion Criteria:

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

Exclusion Criteria:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer

Responsible Party: Maria Silvoniemi, MD, University of Turku
ClinicalTrials.gov Identifier: NCT00818402     History of Changes
Other Study ID Numbers: SILKE-ETMK:47/180/2008
First Posted: January 7, 2009    Key Record Dates
Last Update Posted: May 29, 2015
Last Verified: May 2015

Keywords provided by Maria Silvoniemi, University of Turku:
Quality of life
symptoms

Additional relevant MeSH terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms